Mariko Watanabe

2.4k total citations
94 papers, 1.9k citations indexed

About

Mariko Watanabe is a scholar working on Molecular Biology, Immunology and Cancer Research. According to data from OpenAlex, Mariko Watanabe has authored 94 papers receiving a total of 1.9k indexed citations (citations by other indexed papers that have themselves been cited), including 31 papers in Molecular Biology, 24 papers in Immunology and 17 papers in Cancer Research. Recurrent topics in Mariko Watanabe's work include NF-κB Signaling Pathways (14 papers), Lymphoma Diagnosis and Treatment (10 papers) and T-cell and Retrovirus Studies (9 papers). Mariko Watanabe is often cited by papers focused on NF-κB Signaling Pathways (14 papers), Lymphoma Diagnosis and Treatment (10 papers) and T-cell and Retrovirus Studies (9 papers). Mariko Watanabe collaborates with scholars based in Japan, United States and Australia. Mariko Watanabe's co-authors include Ryouichi Horie, Naoko Yoshie, Toshiki Watanabe, Masaaki Higashihara, Kazue Yamaoka, Marshall E. Kadin, Toshiro Tango, Kazuo Umezawa, Kinji Itoh and Makoto Nakashima and has published in prestigious journals such as Nucleic Acids Research, Blood and PLoS ONE.

In The Last Decade

Mariko Watanabe

90 papers receiving 1.8k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mariko Watanabe Japan 25 555 435 279 256 247 94 1.9k
Li Xiao China 27 719 1.3× 247 0.6× 110 0.4× 161 0.6× 197 0.8× 136 2.6k
Xiaoyan He China 30 1.5k 2.7× 349 0.8× 101 0.4× 274 1.1× 269 1.1× 182 3.0k
Michael H. Allen United Kingdom 34 597 1.1× 1.2k 2.7× 202 0.7× 100 0.4× 295 1.2× 69 3.3k
Kazuhiro Maeda Japan 23 571 1.0× 302 0.7× 185 0.7× 236 0.9× 115 0.5× 89 2.1k
Claudia Schmidt Germany 31 1.3k 2.3× 418 1.0× 117 0.4× 144 0.6× 830 3.4× 83 3.9k
Hee Joo Kim South Korea 24 608 1.1× 357 0.8× 105 0.4× 65 0.3× 117 0.5× 88 1.8k
Zhaoxia Zhang China 25 585 1.1× 92 0.2× 83 0.3× 169 0.7× 218 0.9× 102 1.8k
Lü Long China 38 1.4k 2.5× 261 0.6× 77 0.3× 784 3.1× 280 1.1× 129 4.8k
Junichi Watanabe Japan 26 693 1.2× 205 0.5× 228 0.8× 73 0.3× 305 1.2× 131 2.0k

Countries citing papers authored by Mariko Watanabe

Since Specialization
Citations

This map shows the geographic impact of Mariko Watanabe's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mariko Watanabe with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mariko Watanabe more than expected).

Fields of papers citing papers by Mariko Watanabe

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mariko Watanabe. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mariko Watanabe. The network helps show where Mariko Watanabe may publish in the future.

Co-authorship network of co-authors of Mariko Watanabe

This figure shows the co-authorship network connecting the top 25 collaborators of Mariko Watanabe. A scholar is included among the top collaborators of Mariko Watanabe based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mariko Watanabe. Mariko Watanabe is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Hasegawa, Kiyoshi, et al.. (2021). Clinical indicators useful in decision-making about palliative chemotherapy for end-of-life ovarian cancer patients. Archives of Gynecology and Obstetrics. 305(2). 425–430. 2 indexed citations
3.
Watanabe, Mariko, Akihiro Sugawara, Yoshihiko Noguchi, et al.. (2019). Jietacins, azoxy natural products, as novel NF-κB inhibitors: Discovery, synthesis, biological activity, and mode of action. European Journal of Medicinal Chemistry. 178. 636–647. 13 indexed citations
4.
5.
6.
Watanabe, Mariko, Hiro‐oki Iwakawa, Hisashi Tadakuma, & Yukihide Tomari. (2017). Biochemical and single-molecule analyses of the RNA silencing suppressing activity of CrPV-1A. Nucleic Acids Research. 45(18). 10837–10844. 10 indexed citations
7.
8.
Watanabe, Mariko, Kinji Itoh, Tomiteru Togano, et al.. (2011). Ets-1 Activates Overexpression of JunB and CD30 in Hodgkin's Lymphoma and Anaplastic Large-Cell Lymphoma. American Journal Of Pathology. 180(2). 831–838. 24 indexed citations
9.
Watanabe, Mariko, Kazumi Nakano, Tomiteru Togano, et al.. (2011). Targeted Repression of Overexpressed CD30 Downregulates NF-κB and ERK1/2 Pathway in Hodgkin Lymphoma Cell Lines. Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics. 19(10). 463–469. 21 indexed citations
10.
Takahashi, Keitaro, et al.. (2008). The Earth effects on the supernova neutrino spectra. 2 indexed citations
11.
Miyake, Ariko, Md. Zahidunnabi Dewan, Takaomi Ishida, et al.. (2008). Induction of apoptosis in Epstein-Barr virus-infected B-lymphocytes by the NF-κB inhibitor DHMEQ. Microbes and Infection. 10(7). 748–756. 18 indexed citations
12.
Horie, Ryouichi, Takaomi Ishida, Kinji Ito, et al.. (2007). TRAF activation of C/EBPβ (NF-IL6) via p38 MAPK induces HIV-1 gene expression in monocytes/macrophages. Microbes and Infection. 9(6). 721–728. 24 indexed citations
13.
Dewan, Md. Zahidunnabi, Mariko Watanabe, Kazuo Terashima, et al.. (2005). Hodgkin's lymphoma cells are efficiently engrafted and tumor marker CD30 is expressed with constitutive nuclear factor‐κB activity in unconditioned NOD/SCID/γcnull mice. Cancer Science. 96(8). 466–473. 14 indexed citations
14.
15.
Watanabe, Mariko. (2004). Degradation and formation of bisphenol A in polycarbonate used in dentistry.. PubMed. 51(1). 1–6. 25 indexed citations
16.
Horie, Ryouichi, Mariko Watanabe, Takaomi Ishida, et al.. (2004). The NPM-ALK oncoprotein abrogates CD30 signaling and constitutive NF-κB activation in anaplastic large cell lymphoma. Cancer Cell. 5(4). 353–364. 63 indexed citations
17.
Watanabe, Mariko, Yuji Ogawa, Kinji Ito, et al.. (2003). AP-1 Mediated Relief of Repressive Activity of the CD30 Promoter Microsatellite in Hodgkin and Reed-Sternberg Cells. American Journal Of Pathology. 163(2). 633–641. 41 indexed citations
18.
Horie, Ryouichi, Takuro Watanabe, Kinji Ito, et al.. (2002). Cytoplasmic Aggregation of TRAF2 and TRAF5 Proteins in the Hodgkin-Reed-Sternberg Cells. American Journal Of Pathology. 160(5). 1647–1654. 50 indexed citations
19.
Moritaka, Hatsue, et al.. (2001). Effect of Moderate Exercises on Preference for Organic Acid. 5(2). 118–126. 1 indexed citations
20.
Imai, Yohji, et al.. (1999). Effect of blending tricalcium phosphate on hydrolytic degradation of a block polyester containing poly(L-lactic acid) segment. Journal of Biomaterials Science Polymer Edition. 10(7). 773–786. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Li Xiao Breakdown of academic impact, for papers by Xiaoyan He Breakdown of academic impact, for papers by Michael H. Allen Breakdown of academic impact, for papers by Kazuhiro Maeda Breakdown of academic impact, for papers by Claudia Schmidt Breakdown of academic impact, for papers by Hee Joo Kim Breakdown of academic impact, for papers by Zhaoxia Zhang Breakdown of academic impact, for papers by Lü Long Breakdown of academic impact, for papers by Junichi Watanabe
Rankless by CCL
2026